- Home
- IAE vs IMRX Comparison
IAE vs IMRX Comparison
Compare IAE & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAE
- IMRX
- Stock Information
- Founded
- IAE 2007
- IMRX 2008
- Country
- IAE United States
- IMRX United States
- Employees
- IAE N/A
- IMRX N/A
- Industry
- IAE Trusts Except Educational Religious and Charitable
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- IAE Finance
- IMRX Health Care
- Exchange
- IAE Nasdaq
- IMRX Nasdaq
- Market Cap
- IAE 71.1M
- IMRX 73.2M
- IPO Year
- IAE N/A
- IMRX 2021
- Fundamental
- Price
- IAE $6.20
- IMRX $1.80
- Analyst Decision
- IAE
- IMRX Buy
- Analyst Count
- IAE 0
- IMRX 7
- Target Price
- IAE N/A
- IMRX $12.60
- AVG Volume (30 Days)
- IAE 46.3K
- IMRX 349.0K
- Earning Date
- IAE 01-01-0001
- IMRX 11-13-2024
- Dividend Yield
- IAE 10.21%
- IMRX N/A
- EPS Growth
- IAE N/A
- IMRX N/A
- EPS
- IAE N/A
- IMRX N/A
- Revenue
- IAE N/A
- IMRX N/A
- Revenue This Year
- IAE N/A
- IMRX N/A
- Revenue Next Year
- IAE N/A
- IMRX N/A
- P/E Ratio
- IAE N/A
- IMRX N/A
- Revenue Growth
- IAE N/A
- IMRX N/A
- 52 Week Low
- IAE $5.31
- IMRX $1.00
- 52 Week High
- IAE $6.45
- IMRX $8.89
- Technical
- Relative Strength Index (RSI)
- IAE 32.20
- IMRX 42.88
- Support Level
- IAE $6.28
- IMRX $1.68
- Resistance Level
- IAE $6.51
- IMRX $2.17
- Average True Range (ATR)
- IAE 0.08
- IMRX 0.14
- MACD
- IAE -0.03
- IMRX -0.01
- Stochastic Oscillator
- IAE 11.70
- IMRX 24.02
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.